ASCO 2020：11项中国研究入选为口头报告，17项Poster报告

倍受全球最初冠疫情直接影响，原计划于5月29日~6月2日在芝加哥举行的最初泽西州诊断学会（ASCO）年会今年将首次以线上型式举办，这是目前最大规模的线上盛会。那时候，小组会议的摘录题目揭晓，共103个sessions，华南地区共约11项数据深入研究入选口头报告，17项入选Poster

Pyrotinib or lapatinib plus capecitabine for HER2+ metastatic breast cancer (PHOEBE): A randomized phase III trial.Session: Breast Cancer—MetastaticAuthor(s): Binghe Xu, Min Yan, Fei Ma, Xi-Chun Hu, Ji Feng Feng, Quchang Ouyang, Zhongsheng Tong, Huiping Li, Qingyuan Zhang, Tao Sun, Xian Wang, Yongmei Yin, Ying Cheng, Wei Li, Xiaoyu Zhu, Chunxia Chen, Jianjun ZouAbstract: 1003

过氧化替尼或拉帕替尼加卡培他滨用作HER2+心肌梗死乳腺肠胃癌（PHOEBE）：一项III期随机试验中。

嘉年华：心肌梗死乳腺肠胃癌

写作者：华南地区医学科学院疗养院徐兵河客座教授、马飞客座教授，北京师范大学附属疗养院胡夕春客座教授等

摘录号：1003

Phase III trial of metronomic capecitabine maintenance after standard treatment in operable triple-negative breast cancer (SYSUCC-001).

Session: Breast Cancer—Local/Regional/Adjuvant

Author(s): XI Wang, Shu-Sen Wang, Heng Huang, Li Cai, Rou-Jun Peng, Li Zhao, Ying Lin, Jian Zeng, Le-Hong Zhang, Yong-Li Ke, Xian-Ming Wang, Xin-Mei Liu, Qian-Jun Chen, An-Qin Zhang, Dan-Mei Pang, Fei Xu, Jia J. Huang, Yanxia Shi, Jun Tang, Zhongyu Yuan

Abstract: 507

可手术三中性乳腺肠胃癌准则治疗法后卡培他滨保有节奏抗生素的III期试验中（SYSUCC-001）。

嘉年华：乳腺肠胃癌—局部/区域内/专门设计治疗法

写作者：里山大学禁毒一个里心王之树森客座教授等

摘录号：507

Utilizing phenotypic characteristics of metastatic brain tumors to predict the probability of circulating tumor DNA detection from cerebrospinal fluid.Session: New Tools to Combat Old FoesAuthor(s): Meichen Li, Delan Li, Xue Hou, Xiangheng Zhang, Na Wang, Jianzhong Liang, Jing Chen, Kaicheng Wang, Fufeng Wang, Yedan Chen, Xian Zhang, Hua Bao, Xue Wu, Xiaonan Wang, Yang Shao, Likun ChenAbstract: 2507

运用心肌梗死脑的表现型不同之处来计算脑脊液里循环DNA样品的机率: 最初工具对抗据说输掉

嘉年华：最初工具解决据说疑问

写作者：李美芹 李科克等

摘录号: 2507

Donafenib versus sorafenib as first-line therapy in advanced hepatocellular carcinoma: An open-label, randomized, multicenter phase II/III trial.

Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Author(s): Feng Bi, Shukui Qin, Shanzhi Gu, Yuxian Bai, Zhendong Chen, Zishu Wang, Jieer Ying, Yinying Lu, Zhiqiang Meng, Hongming Pan, Ping Yang, Helong Zhang, Xi Chen, Aibing Xu, Xiufeng Liu, Qiu Meng, Liqing Wu, Feng Chen

Abstract: 4506

罗萨非尼对比索拉非尼作为里叶人体内内肠胃癌的一线治疗法：一项开放ID、随机、多一个里心II/III期试验中。

嘉年华：十二指肠肠道肠胃癌—十二指肠十二指肠、肾上腺和实乃

写作者：重庆大学亚东疗养院毕锋客座教授、国民解放军八一疗养院秦叔逵客座教授等

摘录号：4506

Apatinib as second-line therapy in Chinese patients with advanced hepatocellular carcinoma: A randomized, placebo-controlled, double-blind, phase III study.

Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Author(s): Qiu Li, Shukui Qin, Shanzhi Gu, Xiaoming Chen, Lizhu Lin, Zishu Wang, Aibing Xu, Xi Chen, Cuncai Zhou, Zhenggang Ren, Lin Yang, Li Xu, Yuxian Bai, Lei Chen, Jun Li, Hongming Pan, Bangwei Cao, Weijia Fang, Ping Yan, Chunlei Jin

Abstract: 4507

华南地区里叶肠胃肠胃癌高血压阿帕替尼一线治疗法：一项随机、双盲对照、双盲III期数据深入研究

嘉年华：十二指肠肠道肠胃癌—十二指肠十二指肠、肾上腺和实乃

写作者：国民解放军八一疗养院秦叔逵客座教授、重庆大学亚东疗养院李秋客座教授等

摘录号：4507

A randomized phase III trial of secondary cytoreductive surgery in later recurrent ovarian cancer: SOC1/SGOG-OV2.

Session: Gynecologic Cancer

Author(s): Rongyu Zang, Jianqing Zhu, Tingyan Shi, Jihong Liu, Dongsheng Tu, Sheng Yin, Rong Jiang, Ping Zhang, Huixun Jia, Yuting Luan, Yuqin Zhang, Xiaojun Chen, Xiao Huang, Wenjuan Tian, Wen Gao, Yanling Feng, Huijuan Yang, Xi Cheng, Yulang Cai

Abstract: 6001

里叶发作性卵巢肠胃癌二次蛋白减灭术的一项随机III期试验中：SOC1 / SGOG-OV2。

简介：护理人员肠胃结核病

写作者：北京师范大学附属里山疗养院臧荣余客座教授等

摘录：6001

Sequential chemoradiation versus radiation alone or concurrent chemoradiation in adjuvant treatment after radical hysterectomy for stage IB1-IIA2 cervical cancer (STARS Study): A randomized, controlled, open-label, phase III trial.

Session: Gynecologic Cancer

Author(s): He Huang, Yanling Feng, Ting Wan, Yanna Zhang, Xinping Cao, Yongwen Huang, Ying Xiong, Xin Huang, Min Zheng, Yanfang Li, Jundong Li, Guandi Chen, Hu Li, Yile Chen, Liguo Ma, Hongying Yang, Li Li, Shuzhong Yao, Qing Liu, Jihong Liu

Abstract: 6007

IB1-IIA2期宫颈肠胃癌根治性子宫切除后专门设计治疗法里的序贯放抗生素对比之外放疗或并行放抗生素（STARS数据深入研究）：一项随机、对照、开放ID的III期试验中。

小组会议：护理人员肠胃结核病

写作者：里山大学禁毒一个里心苍客座教授、刘继红客座教授等

摘录号：6007

CTONG1104: Adjuvant gefitinib versus chemotherapy for resected N1-N2 NSCLC with EGFR mutation—Final overall survival ysis of the randomized phase III trial 1 ysis of the randomized phase III trial.

Session: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Author(s): Yi-Long Wu, Wenzhao Zhong, Qun Wang, Weimin Mao, Song-Tao Xu, Lin Wu, Chun Chen, Ying Cheng, Lin Xu, Jun Wang, Xiao-Fei Li, Jian Li, Cheng Huang, Zhidong Liu, Shun Xu, Jin-Ji Yang, Hong-Hong Yan, Xue-Ning Yang, Si-yang Liu, Qing Zhou

Abstract: 9005

CTONG1104：专门设计吉非替尼对比抗生素用作可切除的EGFR基因突变的N1-N2期NSCLC-随机III期诊断试验中的最终总体生存深入研究。

简介：肺肠胃癌—非小蛋白局部-区域内/小蛋白/其他胸部

写作者：广东省国民疗养院吴一龙客座教授等

摘录号：9005

First-line tyrosine kinase inhibitor with or without aggressive upfront local radiation therapy in patients with EGFRm oligometastatic non-small cell lung cancer: Interim results of a randomized phase III, open-label clinical trial (SINDAS) (NCT02893332).

Session: Lung Cancer—Non-Small Cell Metastatic

Author(s): Xiaoshan Wang, Ming Zeng

Abstract: 9508

EGFR基因突变无以分散非小蛋白肺肠胃癌高血压一线半胱氨酸激酶肽共同或不共同务实主力部队局部放疗：III期开放ID诊断随机试验中（SINDAS）的里期结果（NCT02893332）。

简介：肺肠胃癌-非小蛋白分散

写作者：四川省国民疗养院曾铭客座教授等

摘录：9508

Overall survival and biomarker ysis of a phase Ib combination study of toripalimab, a humanized IgG4 mAb against programmed death-1 (PD-1) with axitinib in patients with metastatic mucosal melanoma.

Session: Melanoma/Skin Cancers

Author(s): Xinan Sheng, Xieqiao Yan, Zhihong Chi, Lu Si, Chuanliang Cui, Bixia Tang, Siming Li, Lili Mao, BIN LIAN, Xuan Wang, Xue Bai, Li Zhou, Yan Kong, Jie Dai, Keith Flaherty, Jun Guo

Abstract: 10007

Toripalimab，一种针对某类死亡-1（PD-1）的人源化IgG4单克隆抗体共同阿昔替尼用作心肌梗死黏膜黑色素糙高血压的Ib期数据深入研究的总生存期和生命体；也深入研究。

简介：黑色素糙/皮肤肠胃癌

写作者：北京大学疗养院郭军、盛锡楠客座教授等

摘录：10007

Safety and efficacy results of GC027: The first-in-human, universal CAR-T cell therapy for relapsed/refractory T-cell acute lymphoblastic leukemia (r/r T-ALL).Session: Developmental Therapeutics—ImmunotherapyAuthor(s): Xinxin Wang, Shiqi Li, Lei Gao, Zhongtao Yuan, Kun Wu, Lin Liu, Le Luo, Yao Liu, Cheng Zhang, Jia Liu, Chunhui Yang, Yu Li, Jiaping He, Xun Ye, Zhimin Li, Xu Tan, Jianning Ge, Wei Cao, Sanbin Wang, Xi ZhangAbstract: 3013Poster: 77 GC027的耐用性和结果：通用CAR-T蛋白首次人体内试验中治疗法发作/难治性T蛋白急性淋巴蛋白帕金森氏症（r/r T-ALL）的耐用性和。小组会议：技术开发里的治疗法技术-免疫治疗法。写作者：王之欣欣等摘录：3013广告：77 Sintilimab in patients with advanced esophageal squamous cell carcinoma refractory to previous chemotherapy: A randomized, open-label phase II trial (ORIENT-2).Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and HepatobiliaryAuthor(s): Jianming Xu, Yi Li, Qingxia Fan, Yongqian Shu, Zhijun Wu, Tongjian Cui, Kangsheng Gu, Min Tao, Xiuwen Wang, Chengxu Cui, Nong Xu, Juxiang Xiao, Quanli Gao, Yunpeng Liu, Tao Zhang, Hui Zhou, Yan Wang, Linxinyu Xu, Zhuo Ma, Yanqi WangAbstract: 4511Poster: 119 信迪利唑在里叶十二指肠结节蛋白肠胃癌高血压里的广泛应用：一项随机的开放IDII期试验中（ORIENT-2）。小组会议：十二指肠肠道肠胃癌-十二指肠十二指肠肠胃癌、肾上腺肠胃癌和实乃道肠胃癌写作者：徐建明客座教授等摘录：4511广告：119 Eradication of medulloblastoma by NKG2D-specific CAR T-cells.Session: Central Nervous System TumorsAuthor(s): Hong-jiu Dai, Bin Sun, Dong Yang, Hui Xu, Jingjing Zhu, Jia Wei, Xudong ZhaoAbstract: 2522Poster: 13 NKG2D特异性CAR-T蛋白对子叶母蛋白糙的根绝性治疗法小组会议：里枢神经系统写作者：代红久、孙斌、杨东、徐晖、朱晶晶、魏佳、赵旭东摘录：2522广告。13 Envafolimab (KN035) in advanced tumors with mismatch-repair deficiency.Session: Developmental Therapeutics—ImmunotherapyAuthor(s): Lin Shen, Jian Li, Yanhong Deng, Weijie Zhang, Aiping Zhou, Weijian Guo, Jianwei Yang, Ying Yuan, Liangjun Zhu, Shukui Qin, Silong Xiang, Haolan Lu, John Gong, Ting Xu, Did LiuAbstract: 3021Poster: 85 Envafolimab（KN035）在里叶错配修复缺陷高血压里的广泛应用小组会议：技术开发里的治疗法学-免疫治疗法写作者：沈琳客座教授等摘录：3021广告。85 First-in-human clinical trial of the autologous CD7-CART for relapsed/refractory ACUTE lymphoblastic leukemia/lymphoma.Session: Developmental Therapeutics—ImmunotherapyAuthor(s): Mingzhi Zhang, Lin Yang, Xiaorui Fu, Lei Zhang, Huimin Meng, Ling Li, Xin Li, Xinhua Wang, Zhenchang Sun, Hui Yu, Zhaoming Li, Feifei Nan, Yu Chang, Zhiyuan Zhou, Jiaqin Yan, Jiwei Li, Min Wang, Fengtao You, Yu-Sheng Chen, Bozhen ZhangAbstract: 3026Poster: 90 自体CD7-CART治疗法发作/难治性ACUTE淋巴蛋白帕金森氏症/结核病的首例人体内诊断试验中小组会议: 技术开发性治疗法学-免疫治疗法写作者简介：张明志，板桥乡等摘录：3026广告: 90 A phase Ib study of simmitecan (LP) single-agent and in combination with 5-fluorouracil/leucovorin (5-FU/LV) or thalidomide (T) in patients with advanced solid tumor.Session: Developmental Therapeutics—Molecularly Targeted Agents and Tumor BiologyAuthor(s): Jifang Gong, Ting Deng, Jie Li, Ming Lu, Jian Li, Yi Ba, Qiuqiong Yu, Lin ShenAbstract: 3523Poster: 253 西米替康（LP）单药和5-氟尿嘧啶/白藜芦醇（5-FU/LV）或沙利度羟基（T）共同广泛应用作里叶实体糙高血压的Ib期数据深入研究小组会议：发展性治疗法学----化学键靶向类固醇和药理学写作者：龚继芳，沈琳客座教授等摘录：3523广告：253 A phase II study of rh-endostatin combined with paclitaxel and nedaplatin in treating patients with recurrent or metastatic esophageal squamous cell carcinoma (ESCC).Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and HepatobiliaryAuthor(s): Zhiqiang Wang, Yu-Hong Li, De-Shen Wang, Fenghua Wang, Chao Ren, Qiong TanAbstract: 4522Poster: 130 Rh-endostatin共同紫杉醇和nedaplatin治疗法发作性或心肌梗死十二指肠结节蛋白肠胃癌（ESCC）高血压的II期数据深入研究。小组会议：十二指肠肠道肠胃癌-十二指肠十二指肠、肾上腺和实乃道肠胃癌的数据深入研究写作者：王之志不强，李玉红，王之德申，王之凤华，任超，谭琼 王之志不强、李玉红、王之德深、王之凤华、任超、谭琼摘录：4522广告：130 HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric adenocarcinoma: A phase II clinical trial.Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and HepatobiliaryAuthor(s): Yan Song, Ning Li, Lan Mu, Shu Zhang, Qingxia Fan, Xinjun Liang, Xianli Yin, Zhixiang Zhuang, Yunpeng Liu, Jingdong Zhang, Xiaoge Kou, Haijun Zhong, Jing HuangAbstract: 4524Poster: 132 HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric adenocarcinoma: A phase II clinical trial.小组会议：十二指肠肠道肠胃癌-十二指肠十二指肠肠胃癌、肾上腺肠胃癌和实乃管肠胃癌的一线治疗法写作者：宋艳等摘录：4524广告：132 A urine exosomal circRNA classifier for detection of high-grade prostate cancer at initial biopsy: A multicenter, retrospective study.Session: Genitourinary Cancer—Prostate, Testicular, and PenileAuthor(s): Liaoyuan Li, Wen Tao, Yadi He, Tao He, Qing Li, Zhenquan Wu, Weiming Deng, Lingxiao ZhangAbstract: 5522Poster: 103 一种血液外体环状RNA线性系统用作初始切片时样品高等级肠胃癌的血液外体环状RNA线性系统：一项多一个里心的回顾性数据深入研究小组会议：移行睾丸肠胃结核病--------肠胃癌、睾丸肠胃癌和肠胃癌写作者简介：Liaoyuan Li等摘录：5522广告。103 Adjuvant chemotherapy after concurrent chemoradiation therapy for locally advanced cervical cancer.Session: Gynecologic CancerAuthor(s): Lingna Kou, Tao Zhang, Siyun Peng, Yifei Wang, Mingyang Yuan, Minmin LiAbstract: 6031Poster: 202 局部里叶宫颈肠胃癌并发抗生素后的专门设计抗生素小组会议: 护理人员肠胃结核病写作者简介： 李珉珉等摘录：6031广告：202 Association between calcitonin and efficacy of anlotinib in medullary thyroid carcinoma: An ysis based on the ALTER01031 trial.Session: Head and Neck CancerAuthor(s): Ming Gao, Yihebali Chi, Pingzhang Tang, Zhengang Xu, Xiangqian Zheng, Dapeng Li, Xiaohong Chen, Minghua Ge, Yuan Zhang, Zhuming Guo, Jun Wang, Jie Chen, Jiewu Zhang, Ying Cheng, Zhendong Li, Hui Liu, Jianwu Qin, Jingqiang Zhu, Ruochuan ChengAbstract: 6526Poster: 187 降钙素与安罗替尼治疗法骨髓子叶性肠胃癌的差异性：基于ALTER01031试验中的深入研究。会客家话：头颈部写作者：天津市疗养院正派客座教授摘录：6526广告。187 Influence of Eastern Cooperative Oncology Group performance status (ECOG PS), tumor size and age on patient outcomes after anlotinib treatment: A subgroup ysis based on ALTER01031 trial for medullary thyroid carcinoma (MTC).Session: Head and Neck CancerAuthor(s): Ming Gao, Yihebali Chi, Xiangqian Zheng, Dapeng Li, Pingzhang Tang, Zhengang Xu, Xiaohong Chen, Minghua Ge, Yuan Zhang, Zhuming Guo, Jun Wang, Jie Chen, Jiewu Zhang, Ying Cheng, Zhendong Li, Hui Liu, Jianwu Qin, Jingqiang Zhu, Ruochuan ChengAbstract: 6527Poster: 188 ECOG PS、大小不一和年龄对安洛替尼治疗法后高血压结局的直接影响: ALTER01031的亚组深入研究小组会议：头颈部写作者：天津市疗养院正派客座教授摘录：6527广告。188 Circulating tumor DNA (ctDNA) ysis predicts recurrence following surgery in patients with stage I-IIIA non-small-cell lung cancer (NSCLC): Results of GASTO1035 and GASTO1018.Session: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic CancersAuthor(s): Si-Yu Wang, Ning Li, Wei Ou, Chao Cheng, Peng-Peng Kuang, Hui-Qi WuAbstract: 9023Poster: 216 ctDNA深入研究计算I-IIIA期非小蛋白肺肠胃癌（NSCLC）高血压术后发作: GASTO1035和GASTO1018的结果小组会议：肺肠胃癌-非小蛋白局部-区域内性/小蛋白/小蛋白/其他胸科肠胃结核病写作者：Si-Yu Wang等摘录：9023广告：216 Exon-16-skipping ERBB2 (ERBB2ΔEx16) as a novel resistance mechanism against EGFR tyrosine kinase inhibitors in non-small cell lung cancer (NSCLC).Session: Lung Cancer—Non-Small Cell MetastaticAuthor(s): Xin Zhao, Linling Jin, Man Yu, Qiuxiang Ou, Hua Bao, Xue Wu, Yang Shao, Min FanAbstract: 9528Poster: 294 ERBB2ΔEx16作为非小蛋白肺肠胃癌（NSCLC）里EGFR半胱氨酸激酶肽的最初型致病选择性小组会议:肺肠胃癌-非小蛋白心肌梗死肺肠胃癌写作者简介：赵昕，金MLT-，满宇，欧秋香，华宝，薛武，杨少，范敏 赵昕、金MLT-、满宇、欧秋香、华宝、薛武、杨绍、范敏摘录：9528广告：294 Surrogate endpoints for overall survival in anti-programmed death-1 and anti-programmed death ligand 1 trials of advanced melanoma.Session: Melanoma/Skin CancersAuthor(s): Run-Cong Nie, Shu-Qiang Yuan, Yuanfang Li, Yingbo Chen, Zhiwei ZhouAbstract: 10030Poster: 379 PD-1/PD-L1试验中前期黑色素糙总生存的替代起始站小组会议：黑色素糙/皮肤肠胃癌写作者：聂润聪，袁书不强，李元芳，陈英波，周志伟 聂润聪、袁书不强、李元芳、陈英波、周志伟摘录：10030广告：379 A phase II study of anlotinib in treating patients with relapsed or metastatic primary malignant bone tumor.Session: SarcomaAuthor(s): Lina Tang, Xiaohui Niu, Zhen Wang, Qiqing Cai, Chongqi Tu, Zhengfu Fan, Yang YaoAbstract: 11525Poster: 413 安罗替尼治疗法发作或心肌梗死原发性恶性突高血压的II期数据深入研究小组会议： 肉糙写作者：唐丽娜，牛晓辉，王之震，蔡启清，涂崇奇，范正福，杨瑶 唐丽娜、牛晓辉、神宗、蔡启庆、涂崇奇、范正福、杨瑶摘录：11525广告。413 Preliminary evaluate the safety and efficacy of anlotinib in advanced sarcoma patients in multi-line therapy.Session: SarcomaAuthor(s): Yao Weitao, Jiaqiang Wang, Peng Zhang, Xin Wang, Xinhui Du, Zhichao Tian, Xiaoying NiuAbstract: 11526Poster: 414 初步赞赏安罗替尼在里叶肉糙高血压多线治疗法里的耐用性和。小组会议：肉糙写作者：姚伟涛，王之家不强，王永，王之欣，杜最初辉，田志浩，牛晓颖 姚伟涛、王之家不强、王永、王之鑫、杜鑫辉、田志超、牛晓英摘录：11526广告：414